Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SGN1 in Advanced Solid Tumors
NCT05103345Phase 2Recruiting
- Sponsor
- Guangzhou Sinogen Pharmaceutical Co., Ltd.
- Start
- Apr 2023
- Primary completion
- Dec 2027
- Modality
- Oncolytic Bacteria, Live Biotherapeutic Products
- Countries
- 2
01
Overview
A Phase 2 trial of SGN1 in solid tumor (advanced stage), sponsored by Guangzhou Sinogen Pharmaceutical Co., Ltd.. Started Apr 2023; status: recruiting.
02
Drugs
SGN1
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT05103345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05103345.